Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Hepatology International|March 23, 2022
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysisJie Ning Yong, Cheng Han Ng, Chloe Wen-Min Lee, et al.
The American Journal of Gastroenterology|October 3, 2022
Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 ParticipantsPhoebe Wen Lin Tay, Cheng Han Ng, Snow Yunni Lin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2022
The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese IndividualsKai En Chan, Cheng Han Ng, Clarissa Elysia Fu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2022
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysisAnsel Tang, Cheng Han Ng, Poh Hui Phang, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2022
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 IndividualsKai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.
Clinical and Molecular Hepatology|October 20, 2022
Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysisDarren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, et al.
Frontiers in Medicine|October 17, 2022
A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)Clarissa Elysia Fu, Cheng Han Ng, Nicholas W S Chew, et al.
Clinical and Molecular Hepatology|March 2, 2022
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individualsAnsel Shao Pin Tang, Kai En Chan, Jingxuan Quek, et al.
Cardiovascular Diabetology|July 12, 2025
Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safetyAnsel Shao Pin Tang, Jovan Teng Yuan Hsu, Sheena Kar Shuan Chong, et al.
Journal of Clinical and Translational Hepatology|November 16, 2022
A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for DyslipidemiaJieling Xiao, Cheng-Han Ng, Yip-Han Chin, et al.
Pageof 3